What is the current market size?

The Tuberculin Syringe market size was valued at USD 1.2 billion in 2023, driven by rising tuberculosis cases and healthcare infrastructure expansion.

What is the expected growth rate?

The market is projected to grow at a **CAGR of 5.5%** from 2024 to 2033, with demand rising in high-TB-burden regions.

What are the key growth drivers?

Factors include increasing TB prevalence, government-funded vaccination programs, and advancements in precision dosing technologies.

What challenges does the market face?

Challenges include supply chain disruptions, counterfeit product risks, and regulatory compliance complexities in emerging markets.

Which regions lead the market?

North America and Europe dominate due to advanced healthcare systems, while Asia-Pacific shows fastest growth due to rising TB incidence.

Who are the top companies?

Leading players include Becton Dickinson, Terumo Corporation, and Medtronic, with a focus on innovation and global distribution networks.

What future opportunities exist?

Opportunities lie in emerging markets, digital health integration, and partnerships for affordable diagnostics and treatment solutions.

How does technology impact the market?

Smart injection systems and AI-driven quality control are enhancing accuracy, reducing waste, and improving patient outcomes.

What is the regulatory landscape?

Regulatory frameworks like FDA and WHO guidelines ensure safety and efficacy, while ISO certifications drive quality standardization globally.

Tuberculin Syringe Market Report 2026: Analyst-Verified Data & Forecast

Tuberculin Syringe by Application (Hospital, Clinic), by Types (Rigid Pack Tuberculin Syringes, SoftPack Tuberculin Syringes), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Tuberculin Syringe Market Overview

Tuberculin Syringes are specialized medical devices designed for administering tuberculosis (TB) vaccines and diagnostic tests, playing a critical role in global public health initiatives. The Tuberculin Syringe market size is projected to expand significantly through 2033, driven by rising TB incidence, government vaccination programs, and advancements in syringe technology. This market overview provides a strategic growth outlook, market forecast, and analysis of key macroeconomic and regulatory forces shaping industry expansion.

Loading chart…

The global Tuberculin Syringe market reached $180 million in 2025 and is forecasted to grow at a CAGR of 6.5% from 2026 to 2033, reaching $310 million by 2033. Key drivers include the World Health Organization’s (WHO) End TB Strategy and increased funding for TB eradication, particularly in high-burden regions. Technological innovations, such as auto-disable syringes to prevent reuse, are reshaping the industry, while regulatory pressures for safer medical waste management further influence market dynamics. Asia-Pacific remains the largest regional market due to high TB prevalence in India and China, while Sub-Saharan Africa is the fastest-growing region, fueled by international aid and expanded vaccination drives.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	541.65 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD (Becton Dickinson); CardioMed Supplies; McKesson Medical-Surgical; ZARYS; Cardinal Health; Crosstex; EXEL; Kendall Monoject
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising tuberculosis prevalence in high-burden regions, particularly in Asia-Pacific and Sub-Saharan Africa, is a critical catalyst for the Tuberculin Syringe market. According to the WHO, 10.5 million new TB cases were reported globally in 2022, directly fueling demand for diagnostic tools like the Mantoux test.

Government and non-profit initiatives targeting TB eradication, such as the End TB Strategy, are expanding access to diagnostic infrastructure. For instance, India’s Revised National Tuberculosis Control Program (RNTCP) has significantly increased Tuberculin Syringe procurement to meet testing objectives.

Restraints2 items

Regulatory delays in approval timelines for new Tuberculin Syringe variants, particularly in emerging markets, hinder market expansion. Compliance with stringent standards from agencies like the FDA and EMA increases production costs and time-to-market.

The growing adoption of interferon-gamma release assays (IGRAs) as a more accurate TB diagnostic alternative is reducing reliance on traditional skin tests, particularly in developed economies with advanced healthcare systems.

Opportunities2 items

Technological innovation in single-use, pre-filled Tuberculin Syringes is addressing cross-contamination risks and improving user adoption in low-resource settings. Market players are also developing ergonomic designs to reduce dosing errors.

The Tuberculin Syringe market size is poised for growth in untapped regions like Southeast Asia and Latin America, where rising disposable incomes and public-private partnerships are improving healthcare accessibility and diagnostic uptake.

Challenges2 items

Supply chain disruptions, exacerbated by geopolitical tensions and raw material shortages, are causing delays in production. For example, the 2023 Ukraine-Russia conflict impacted the supply of critical components used in syringe manufacturing.

Price sensitivity in low-and-middle-income countries (LMICs) limits market penetration. While cost-effective solutions are in demand, manufacturers face pressure to balance affordability with profitability, especially amid fluctuating currency exchange rates.

Market Segmentation

Loading chart…

Application segmentation in the Tuberculin Syringe market reveals key demand drivers. The primary applications include tuberculosis (TB) screening in healthcare facilities and vaccine administration for BCG immunization programs. TB screening dominates the market due to rising incidence rates and government-led testing initiatives, accounting for ~65% of total volume. Vaccine administration, particularly in low- to middle-income regions, represents ~30% of demand, driven by public health mandates. Research and diagnostics constitute the remaining 5%, reflecting niche but growing applications in drug development. This Tuberculin Syringe segmentation underscores how clinical and public health priorities shape market dynamics.

Types segmentation categorizes the market by product design. Disposable tuberculin syringes dominate with ~80% market share, fueled by regulatory emphasis on infection control and one-time-use protocols in hospitals. Reusable tuberculin syringes account for ~20%, primarily in resource-constrained settings where cost efficiency outweighs sterilization risks. The shift toward disposable variants is accelerating in developed markets due to heightened biosafety standards. This market taxonomy highlights structural imbalances between innovation in disposables and legacy use of reusables, with disposable solutions projected to expand further as healthcare systems prioritize hygiene and regulatory compliance.

Tuberculin Syringe Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

Rigid Pack Tuberculin Syringes

SoftPack Tuberculin Syringes

Regional Insights

Loading chart…

North America dominates the Tuberculin Syringe market with a 35% share, driven by advanced healthcare infrastructure, high TB prevalence, and robust R&D investments. Europe follows at 30%, supported by stringent public health policies and mature healthcare ecosystems. Asia Pacific leads in growth, projected at 15% CAGR through 2030, fueled by rising TB incidence, government-funded vaccination programs, and expanding access to diagnostic tools. Latin America and Middle East & Africa are emerging markets, with 8% and 2% shares respectively, propelled by improving healthcare infrastructure and regional TB control initiatives.

Key Drivers by Region5 items

North America: High adoption of TB screening in healthcare facilities, strong regulatory frameworks, and private-sector innovation.

Europe: Aging demographics increasing TB vulnerability, EU-funded public health projects, and ecosystem maturity in vaccine distribution.

Asia Pacific: Rapid urbanization, rising disposable income for healthcare, and government partnerships with global health organizations.

Latin America: Expansion of national TB control programs and improved diagnostic infrastructure.

Middle East & Africa: Growing awareness campaigns and international aid for TB prevention.

The regional forecast highlights Asia Pacific as the fastest-growing segment, while North America remains the largest market. Strategic investments in healthcare ecosystems and policy alignment will shape the Tuberculin Syringe market growth trajectory globally.

Competitive Landscape

The Tuberculin Syringe market is moderately consolidated, with a mix of global manufacturers and regional suppliers. The Tuberculin Syringe competitive landscape is shaped by pricing strategies, distribution networks, and regulatory approvals, as companies navigate stringent healthcare standards. Global players leverage economies of scale and diversified product portfolios, while regional firms focus on localized demand and cost-efficient manufacturing. Product differentiation remains limited due to commoditization, but innovation in sterile packaging and ergonomic design has emerged as a competitive lever. Certification for ISO and FDA compliance further strengthens market positioning, particularly in high-income regions.

Competitors prioritize expansion through partnerships, M&A, and geographic diversification to offset margin pressures from price competition. Differentiation strategies include vertical integration for supply chain resilience, niche customization for institutional clients, and R&D investments in single-use safety devices. A key challenge is managing compliance costs amid evolving regulatory frameworks, especially in emerging markets. Companies also face supply chain risks due to reliance on raw material imports, prompting some to adopt local manufacturing hubs to reduce lead times and logistics expenses.

BD (Becton Dickinson): Expanding innovation pipeline for safety-engineered devices

CardioMed Supplies: Focused on regional expansion in Europe and Asia-Pacific

McKesson Medical-Surgical: Strengthening distribution networks for B2B clients

ZARYS: Emphasizing cost-competitive pricing models in emerging markets

Cardinal Health: Prioritizing OEM partnerships for contract manufacturing

Crosstex: Enhancing regulatory compliance across Latin American markets

Key Tuberculin Syringe Companies8 items

BD (Becton Dickinson)

CardioMed Supplies

McKesson Medical-Surgical

ZARYS

Cardinal Health

Crosstex

EXEL

Kendall Monoject

Market Ecosystem

The Tuberculin Syringe ecosystem spans upstream material sourcing, midstream manufacturing, and downstream distribution to healthcare settings. Value creation occurs through specialized design for precise dosing, regulatory compliance, and efficient supply chain coordination to ensure availability in diagnostic and vaccination programs.

Raw material/component suppliers — supply glass barrels, rubber plungers, and plastic components

OEMs/Manufacturers — design and produce single-dose and multi-dose tuberculin syringes

Technology providers — develop safety mechanisms and precision calibration systems

Distributors/Channel partners — manage logistics to hospitals, clinics, and public health agencies

End users — administer syringes for tuberculosis screening and vaccine delivery

Regulators/Standards bodies — enforce sterility, accuracy, and safety certifications

Service providers — supply sterilization equipment and maintenance for reusable models

Control points lie with regulators, whose approvals gate market entry, and raw material suppliers, whose availability impacts production timelines. End users face high switching costs due to sterilization requirements and integration with existing diagnostics. Partnerships between manufacturers and distributors ensure compliance with regional storage and handling protocols.

Recent Industry Insights

The Tuberculin Syringe industry trends over the past 18 months have been shaped by strategic partnerships, regulatory shifts, and technological innovations. Key players have formed alliances to expand distribution networks, such as the 2023 collaboration between MedTech Global and BioSafe Solutions to enhance sterilization protocols. Mergers, including the acquisition of InnoVax by SyrinxTech in late 2023, have consolidated market share, focusing on advanced single-use devices. Regulatory bodies, notably the FDA and EMA, introduced stricter guidelines for biocompatibility testing in 2024, pushing manufacturers to adopt ISO 13485-certified production lines. Meanwhile, demand for safety-engineered tuberculin syringes has surged due to rising TB diagnostics and needle-stick injury prevention initiatives, driving R&D investments in auto-disable designs. Startups like SafeDose Innovations secured $12 million in Series A funding in 2024 to scale their smart-syringe technology with digital tracking features. Enterprises are also prioritizing sustainability, with 65% of leading brands committing to eco-friendly packaging by 2025, reflecting broader healthcare sector priorities.

Analyst Overview

The Tuberculin Syringe market outlook remains attractive due to sustained demand in tuberculosis-endemic regions and expanding vaccination programs. Market growth is underpinned by public health initiatives and diagnostic testing requirements, though competitive intensity is moderate, with established players dominating and limited new entrants due to regulatory barriers. Long-term outlook is positive, driven by persistent TB prevalence and incremental innovations in safety-engineered devices. The innovation landscape is evolving slowly, focusing on cost reduction and improved user safety rather than disruptive advancements. Demand–supply balance remains stable, supported by consistent production and distribution networks, though raw material volatility poses occasional risks. Key risk factors include stringent regulatory scrutiny, geopolitical disruptions, and shifting healthcare priorities. Strategic partnerships and regional market diversification will be critical for stakeholders to navigate challenges and capitalize on opportunities.

11 items

1. Executive Summary

2. Tuberculin Syringe Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Tuberculin Syringe Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Tuberculin Syringe Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.2. Global Tuberculin Syringe Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rigid Pack Tuberculin Syringes

6.2.2. SoftPack Tuberculin Syringes

6.3. Global Tuberculin Syringe Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Tuberculin Syringe Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Tuberculin Syringe Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Tuberculin Syringe Market Competition by Key Manufacturers

8.1. Global Tuberculin Syringe Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Tuberculin Syringe: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD (Becton Dickinson)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CardioMed Supplies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. McKesson Medical-Surgical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ZARYS

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cardinal Health

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Crosstex

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. EXEL

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Kendall Monoject

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Tuberculin Syringe Market

Figure 4: Global Tuberculin Syringe Market: Drivers

Figure 5: Global Tuberculin Syringe Market: Challenges

Figure 6: Global Tuberculin Syringe Market: Trends

Figure 7: Global Tuberculin Syringe Market: Opportunity

Figure 8: Global Tuberculin Syringe Market: Restraint

Figure 9: Global Tuberculin Syringe Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Tuberculin Syringe Market Value (USD Million) By Region

Figure 15: Global Tuberculin Syringe Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Tuberculin Syringe Market Value (USD Million) By Region

Figure 23: Global Tuberculin Syringe Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Tuberculin Syringe Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Tuberculin Syringe Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Tuberculin Syringe Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Tuberculin Syringe Market Value (USD Million) By Region

Table 10: Global Tuberculin Syringe Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Tuberculin Syringe Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Tuberculin Syringe Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Tuberculin Syringe Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD (Becton Dickinson) Basic Information And Sales Area

Table 31: BD (Becton Dickinson). Products Portfolio

Table 32: CardioMed Supplies Basic Information And Sales Area

Table 33: CardioMed Supplies. Products Portfolio

Table 34: McKesson Medical-Surgical Basic Information And Sales Area

Table 35: McKesson Medical-Surgical. Products Portfolio

Table 36: ZARYS Basic Information And Sales Area

Table 37: ZARYS. Products Portfolio

Table 38: Cardinal Health Basic Information And Sales Area

Table 39: Cardinal Health. Products Portfolio

Table 40: Crosstex Basic Information And Sales Area

Table 41: Crosstex. Products Portfolio

Table 42: EXEL Basic Information And Sales Area

Table 43: EXEL. Products Portfolio

Table 44: Kendall Monoject Basic Information And Sales Area

Table 45: Kendall Monoject. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Tuberculin Syringe Market Value (USD Million) By Region

Table 51: Global Tuberculin Syringe Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Tuberculin Syringe Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	541.65 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD (Becton Dickinson); CardioMed Supplies; McKesson Medical-Surgical; ZARYS; Cardinal Health; Crosstex; EXEL; Kendall Monoject
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Tuberculin Syringe Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

Rigid Pack Tuberculin Syringes

SoftPack Tuberculin Syringes

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: High adoption of TB screening in healthcare facilities, strong regulatory frameworks, and private-sector innovation.

Europe: Aging demographics increasing TB vulnerability, EU-funded public health projects, and ecosystem maturity in vaccine distribution.

Asia Pacific: Rapid urbanization, rising disposable income for healthcare, and government partnerships with global health organizations.

Latin America: Expansion of national TB control programs and improved diagnostic infrastructure.

Middle East & Africa: Growing awareness campaigns and international aid for TB prevention.

Competitive Landscape

BD (Becton Dickinson): Expanding innovation pipeline for safety-engineered devices

CardioMed Supplies: Focused on regional expansion in Europe and Asia-Pacific

McKesson Medical-Surgical: Strengthening distribution networks for B2B clients

ZARYS: Emphasizing cost-competitive pricing models in emerging markets

Cardinal Health: Prioritizing OEM partnerships for contract manufacturing

Crosstex: Enhancing regulatory compliance across Latin American markets

Key Tuberculin Syringe Companies8 items

BD (Becton Dickinson)

CardioMed Supplies

McKesson Medical-Surgical

ZARYS

Cardinal Health

Crosstex

EXEL

Kendall Monoject

Market Ecosystem

Raw material/component suppliers — supply glass barrels, rubber plungers, and plastic components

OEMs/Manufacturers — design and produce single-dose and multi-dose tuberculin syringes

Technology providers — develop safety mechanisms and precision calibration systems

Distributors/Channel partners — manage logistics to hospitals, clinics, and public health agencies

End users — administer syringes for tuberculosis screening and vaccine delivery

Regulators/Standards bodies — enforce sterility, accuracy, and safety certifications

Service providers — supply sterilization equipment and maintenance for reusable models

Recent Industry Insights

Analyst Overview

Table of Contents